Skip to main content
Premium Trial:

Request an Annual Quote

NanoInk Wins $735K SBIR Grant to Develop Nanostructures to 'Enhance' Chip Assays

NEW YORK (GenomeWeb News) – NanoInk today said it has won a $735,000 Phase II Small Business Innovation Research grant from the National Human Genome Research Institute to develop "nanostructures” that can “enhance the reproducibility, sensitivity, and spatial density of chip-based assays.”
 
NanoInk said it will do this by developing a patterning methodology based on Dip Pen Nanolithography technology to generate sub-micron sized features on solid surfaces. This method enables materials to be “deposited uniformly in a direct-write fashion on surfaces with nanoscale spatial precision,” Nanolink said in a statement.
 
“This approach offers significant advantages over current microarray printing technologies that suffer from poor location-to-location reproducibility in terms of size, shape, and biomolecule density, as well as reproducibility across microarray slides,” the company said.
 
NanoInk said it will also develop a nanoarray fabrication platform consisting of a DPN arrayer, parallel multipen arrays with integrated microfluidic inking systems and appropriate pen and surface modification chemistry "to allow patterning with a variety of biomolecules."

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.